Summary
In a significant market movement during March 2025, Epoch Biodesign was the subject of a vc funding. The transaction achieved a gross valuation of £14,288,853. Leading the round was UK Government, Lowercarbon Capital, Extantia Capital, Kibo Investments, Inditex Group, Day One Ventures, Happiness Capital.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
UK Government
Lead Investor / Acquirer
Lowercarbon Capital
Lead Investor / Acquirer
Extantia Capital
Lead Investor / Acquirer
Kibo Investments
Lead Investor / Acquirer
Inditex Group
Lead Investor / Acquirer
Day One Ventures
Lead Investor / Acquirer
Happiness Capital
Advising Broker
Undisclosed Firm
Related Deals in Cleantech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in